Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Improvement in metabolic syndrome upon chronic treatment with adenosine receptor antagonist

April 9, 2003

Chymase inhibitor shows potential in preventing aortic aneurysmal dilatation

April 9, 2003

DOV reacquires diltiazem rights from Biovail

April 7, 2003

Integrated pharmacokinetic/pharmacodynamic model developed for SB-480848

April 7, 2003

Orally available ACAT inhibitor described in Kowa patent

April 4, 2003

Pleiotropic cardiovascular effects of pitavastatin

April 4, 2003

Chimeric peptides show high potency in CHF in preclinical studies

April 3, 2003

Cardiovascular effects of MMP inhibitor Ono-4817 discussed at Japanese Circulation Society meeting

April 2, 2003

Chronic T-1032 proves beneficial in dogs with heart failure

April 2, 2003

Further analysis of Lescol LIPS results

April 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...